Latest PERCEPTIVE ADVISORS LLC Stock Portfolio
$4.15Billion– No. of Holdings #107
PERCEPTIVE ADVISORS LLC Performance:
2024 Q2: -12.23%YTD: -3.5%2023: 18.41%
Performance for 2024 Q2 is -12.23%, and YTD is -3.5%, and 2023 is 18.41%.
About PERCEPTIVE ADVISORS LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, PERCEPTIVE ADVISORS LLC reported an equity portfolio of $4.2 Billions as of 30 Jun, 2024.
The top stock holdings of PERCEPTIVE ADVISORS LLC are CERE, FOLD, ACLX. The fund has invested 10.6% of it's portfolio in CEREVEL THERAPEUTICS HLDNG I and 6.7% of portfolio in AMICUS THERAPEUTICS INC.
The fund managers got completely rid off INHIBRX INC (INBX), FUSION PHARMACEUTICALS INC (FUSN) and SAREPTA THERAPEUTICS INC (SRPT) stocks. They significantly reduced their stock positions in AXOGEN INC (AXGN), TACTILE SYS TECHNOLOGY INC (TCMD) and IRHYTHM TECHNOLOGIES INC (IRTC). PERCEPTIVE ADVISORS LLC opened new stock positions in CONTINEUM THERAPEUTICS INC, MERUS N V (MRUS) and CULLINAN THERAPEUTICS INC (CGEM). The fund showed a lot of confidence in some stocks as they added substantially to ARCUTIS BIOTHERAPEUTICS INC (ARQT), ACRIVON THERAPEUTICS INC and INTRA-CELLULAR THERAPIES INC (ITCI).
The top stock holdings of PERCEPTIVE ADVISORS LLC are CERE, FOLD, ACLX. The fund has invested 10.6% of it's portfolio in CEREVEL THERAPEUTICS HLDNG I and 6.7% of portfolio in AMICUS THERAPEUTICS INC.
The fund managers got completely rid off INHIBRX INC (INBX), FUSION PHARMACEUTICALS INC (FUSN) and SAREPTA THERAPEUTICS INC (SRPT) stocks. They significantly reduced their stock positions in AXOGEN INC (AXGN), TACTILE SYS TECHNOLOGY INC (TCMD) and IRHYTHM TECHNOLOGIES INC (IRTC). PERCEPTIVE ADVISORS LLC opened new stock positions in CONTINEUM THERAPEUTICS INC, MERUS N V (MRUS) and CULLINAN THERAPEUTICS INC (CGEM). The fund showed a lot of confidence in some stocks as they added substantially to ARCUTIS BIOTHERAPEUTICS INC (ARQT), ACRIVON THERAPEUTICS INC and INTRA-CELLULAR THERAPIES INC (ITCI).
PERCEPTIVE ADVISORS LLC Equity Portfolio Value
Last Reported on: 16 Aug, 2024
PERCEPTIVE ADVISORS LLC Annual Return Estimates Vs S&P 500
Our best estimate is that PERCEPTIVE ADVISORS LLC made a return of -12.23% in the last quarter. In trailing 12 months, it's portfolio return was 14.5%.
New Buys
| Ticker | $ Bought |
|---|---|
| contineum therapeutics inc | 27,589,000 |
| merus n v | 17,751,000 |
| rapport therapeutics inc | 17,402,700 |
| inhibrx biosciences inc | 15,077,200 |
| cullinan therapeutics inc | 13,078,500 |
| insmed inc | 12,060,000 |
| bicycle therapeutics plc | 11,577,300 |
| icon plc | 9,795,940 |
New stocks bought by PERCEPTIVE ADVISORS LLC
Additions
| Ticker | % Inc. |
|---|---|
| arcutis biotherapeutics inc | 107 |
| acrivon therapeutics inc | 78.23 |
| immatics n.v | 76.46 |
| intra-cellular therapies inc | 62.64 |
| zymeworks inc | 55.16 |
| tyra biosciences inc | 50.54 |
| livanova plc | 48.49 |
| iovance biotherapeutics inc | 34.56 |
Additions to existing portfolio by PERCEPTIVE ADVISORS LLC
Reductions
| Ticker | % Reduced |
|---|---|
| axogen inc | -98.04 |
| tactile sys technology inc | -93.06 |
| irhythm technologies inc | -85.64 |
| cabaletta bio inc | -65.92 |
| medtronic plc | -65.68 |
| axsome therapeutics inc | -58.46 |
| adma biologics inc | -56.93 |
| viridian therapeutics inc | -55.38 |
PERCEPTIVE ADVISORS LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| fusion pharmaceuticals inc | -145,517,000 |
| autolus therapeutics plc | -27,630,200 |
| inhibrx inc | -148,793,000 |
| treace med concepts inc | -30,079,600 |
| landos biopharma inc | -31,940,600 |
| rapt therapeutics inc | -10,986,800 |
| immunitybio inc | -5,654,000 |
| cogent biosciences inc | -5,936,000 |
PERCEPTIVE ADVISORS LLC got rid off the above stocks
Sector Distribution
PERCEPTIVE ADVISORS LLC has about 87.1% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 87.1 |
| Others | 12.7 |
Market Cap. Distribution
PERCEPTIVE ADVISORS LLC has about 5.4% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 55.2 |
| SMALL-CAP | 23.5 |
| UNALLOCATED | 12.8 |
| LARGE-CAP | 5.4 |
| MICRO-CAP | 2.9 |
Stocks belong to which Index?
About 72.4% of the stocks held by PERCEPTIVE ADVISORS LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 70.8 |
| Others | 27.6 |
| S&P 500 | 1.6 |
PERCEPTIVE ADVISORS LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC has 107 stocks in it's portfolio. About 47.2% of the portfolio is in top 10 stocks. IOVA proved to be the most loss making stock for the portfolio. ADMA was the most profitable stock for PERCEPTIVE ADVISORS LLC last quarter.
Last Reported on: 16 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABBV | abbvie inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ABSI | absci corporation | 0.05 | 700,000 | 2,156,000 | unchanged | 0.00 | ||
| ACLX | arcellx inc | 5.17 | 3,889,740 | 214,675,000 | reduced | -1.11 | ||
| ADMA | adma biologics inc | 0.75 | 2,771,000 | 30,979,800 | reduced | -56.93 | ||
| AGLE | spyre therapeutics inc | 1.72 | 3,031,020 | 71,259,200 | added | 18.55 | ||
| AKRO | akero therapeutics inc | 0.85 | 1,499,900 | 35,187,600 | added | 8.1 | ||
| ALDX | aldeyra therapeutics inc | 0.74 | 9,275,850 | 30,703,100 | added | 7.94 | ||
| ALLO | allogene therapeutics inc | 0.15 | 2,725,000 | 6,349,250 | new | |||
| AORT | artivion inc | 1.73 | 2,793,700 | 71,658,500 | added | 4.67 | ||
| APLT | applied therapeutics inc | 0.90 | 8,005,000 | 37,383,400 | unchanged | 0.00 | ||
| ARQT | arcutis biotherapeutics inc | 0.35 | 1,558,500 | 14,494,000 | added | 107 | ||
| ARVN | arvinas inc | 0.66 | 1,027,750 | 27,358,700 | reduced | -16.89 | ||
| ATHA | athira pharma inc | 0.34 | 5,402,960 | 14,317,900 | unchanged | 0.00 | ||
| ATXS | astria therapeutics inc | 1.42 | 6,485,420 | 59,017,300 | unchanged | 0.00 | ||
| AUTL | autolus therapeutics plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AXGN | axogen inc | 0.00 | 30,421 | 220,248 | reduced | -98.04 | ||
| AXSM | axsome therapeutics inc | 0.89 | 459,111 | 36,958,400 | reduced | -58.46 | ||
| BBIO | bridgebio pharma inc | 0.74 | 1,215,350 | 30,784,700 | reduced | -13.93 | ||
| BCYC | bicycle therapeutics plc | 0.28 | 572,000 | 11,577,300 | new | |||
| BDSX | biodesix inc | 0.08 | 2,173,880 | 3,326,040 | new | |||